Ferritin Quantitative Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

Product Detail

Application


The SARS-CoV-2 Antigen Rapid Qualitative Test is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in human nasal swabs samples from individuals who are suspected of COVID-19. The test is intended as an aid in diagnosis of symptomatic individuals within the first 7 days of symptom onset.


Product Features


Fast Result
Easy-to-use
High specificity and sensitivity
Room temperature storage


Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the 25-hydroxyvitamin D (25 (OH) D) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of health check.
FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)
FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free thyroxine 4 (FT4) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.
biotime NGAL Rapid Quantitative Test
NGAL Rapid Quantitative Test
NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any significant rise in serum creatinine.
hs cTnI Rapid Quantitative Test
hs cTnI Rapid Quantitative Test
cTnI, a crucial cardiac biomarker, assists in detecting and managing acute myocardial infarction and assessing patient risk in cardiovascular events. Biotime's hs-cTnI offers high sensitivity, compatibility with versatile samples, and stable performance. Trust our ideal biomarker for comprehensive acute coronary syndrome evaluation.
Biotime fT4 Rapid Quantitative Test
fT4 Rapid Quantitative Test
Thyroxine (T4) is the main thyroid hormone secreted into the bloodstream by the thyroid gland. Together with triiodothyronine (T3) it plays a vital role in regulating the body's metabolic rate, influences the cardiovascular system, growth and bone metabolism, and is important for normal development of gonadal functions and nervous system.
FIA Analyzer
FLI-100 FIA Analyzer
The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
Biotime ST2 Rapid Quantitative Test
ST2 Rapid Quantitative Test
ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. The studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact